After completing this activity, participants should be able to:
Explain why autism is now considered a prenatal neural developmental disorder
Describe what new biomarkers offer potential as diagnostic and prognostic markers
Explain why discovery of diagnostic and prognostic could impact future treatment research designs
Describe how the NIMH-funded Get S.E.T Early Services Program can be implemented and how it can improve early detection, early evaluation and early treatment referral for infants at risk for ASD
Describe new scientific and clinical information parents need to know to make decisions about vaccination of their child, to understand about autism, its early signs, its biological bases, it heterogeneous development and clinical outcome, and its treatment
Effectively find community services for toddlers and children with autism and their parents.
The target audience for this program includes pediatricians, nurses, parents, teachers, treatment providers, medical students and residents, psychologists, neuroscientists, psychiatrists, OT, PT and behavioral therapists.
The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 5.25
AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.
AAP: This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 5.25 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.
BRN: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts 5.25
AMA PRA Category 1 Credits™ (report up to hours of credit and list "CME Category 1" as the provider number).
Eric Courchesne, Ph.D. ACE Director (Professor, UCSD Department of Neurosciences)
Karen Pierce, Ph.D. ACE Assistant Director (Associate Professor, UCSD Department of Neurosciences)
Jonathan Sebat, Ph.D. (Associate Professor, Department of Psychiatry)
Alysson Muotri, Ph.D. (Assistant Professor, Department of Pediatrics)
Sharon Leon, (Co-President NFAR)
Juan Leon, (Co-President NFAR)
Len Levin, Ph.D. (Director, Coyne and Associates)
Doris Trauner, M.D. (Professor, UCSD Departments of Neurosciences and Pediatrics)
Elizabeth Rosenblum, M.D. (Clinical Professor, Dept. of Family & Preventive Medicine; Dept. of Reproductive Medicine)
|Opening Welcome||8:45-9:00 a.m. |
New Breakthroughs in Science |
|Eric Courchesne, Ph.D.||Autism is a Prenatal Disorder||9:00-9:30|
|Karen Piece, Ph.D.||Early BIomarkers of ASD||9:40-10:10|
|Jonathan Sebat, Ph.D.||Genetics of ASD||10:30-11:00|
|Alysson Muotri, Ph.D.||Modeling Autism with Stem Cells||11:10-11:40|
LUNCH|| ||12:00-1:00 |
The Community and You|
|Karen Pierce, Ph.D.||The GET Set Early Model||1:00-1:20 p.m.|
|Sharon and Juan Leon||The GET Set Early Model, Latino Outreach Program, Parent Support and Tech|
Training for ASD Adults
|Len Levin, Ph.D.|
|Intervention for newly diagnosed children, ages 12 months to 3 years old|
|Doris Trauner, M.D. ||The Child Neurologist's Approach to Autism|
|Elizabeth Rosenblum, M.D.||
Wrap-up/Participant Survey||3:40-4:00 |
Disclosure Statement It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.
Cultural and Linguistic Competency Statement
This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the CSD CME website at http://cme.ucsd.edu.